Analyst Ratings for Sana Biotechnology (SANA)
SANA Rating Summary
SANA Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.33 (+143.7%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
Avg. $ Target:
$9.33 (+143.7%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/22/2026 | TD Cowen | Phil Nadeau | New Coverage | Buy (N/A) |
N/A (N/A) |
3.74 (3.83) |
2.41% | Details |
| 5/11/2026 | Rodman & Renshaw | Michael King Jr. | New Coverage | Buy (N/A) |
16.00 (N/A) |
3.51 (3.83) |
9.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
